Amgen to Showcase Innovations at the 2026 Global Healthcare Conference

Amgen, a leading global biotechnology company, will take the stage at the 2026 Leerink Partners Global Healthcare Conference scheduled for March 11, 2026, at 9:20 a.m. ET. This important event will feature key insights shared by Peter Griffith, Amgen’s Executive Vice President and Chief Financial Officer, alongside Jasper van Grunsven, the Senior Vice President of Rare Disease.

The conference will be accessible to the public through a live webcast that Amgen will host on their website, allowing not only investors but also media representatives and the general public to tune in. Attendees can expect to gain valuable information regarding new developments and innovative solutions in healthcare that Amgen is pursuing. This event is part of Amgen's commitment to transparency and engagement with stakeholders across the board.

The webcast will be archived and available for replay for a minimum of 90 days after the conference, ensuring that those who are unable to attend live can still access the vital information presented.

About Amgen

With a firm commitment to discovering, developing, and manufacturing innovative medicines, Amgen has been at the forefront of the biotechnology industry for over 45 years. Headquartered in Thousand Oaks, California, the company has proven itself an industry leader by harnessing advanced technologies and genetic data to create therapies that address some of the toughest diseases known today.

Amgen’s robust portfolio encompasses treatments for cancer, inflammatory diseases, rare disorders, heart conditions, and obesity-related ailments. The company continuously strives for innovation and has received accolades for its outstanding workplace culture, recognized by renowned publications such as Fast Company and Forbes.

Additionally, Amgen is well-represented in top stock indices, being one of the select companies in the Dow Jones Industrial Average and the Nasdaq-100 Index, reflecting its market significance and commitment to innovation.

For more detailed updates about the conference and other company developments, stakeholders can visit Amgen's dedicated Investor Relations section on their official website at www.amgen.com. There, they can find further information regarding upcoming presentations, event timings, and access web links. Furthermore, Amgen encourages everyone to follow their journey on various social media platforms such as X, LinkedIn, Instagram, YouTube, Facebook, TikTok, and Threads.

Contact Information

If you have any questions or need more information, please reach out to the Amgen Media Relations team:

- Elissa Snook: 609-251-1407 (media inquiries)
- Casey Capparelli: 805-447-1746 (investor relations)

Amgen remains dedicated to enhancing patient lives through innovative therapies and looks forward to sharing their progress at the forthcoming healthcare conference.